These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Understanding the Benefits of CO Jankovic S; Rovcanin M; Tomic A; Jurisic A; Milovanovic Z; Zamurovic M Medicina (Kaunas); 2024 Jun; 60(7):. PubMed ID: 39064488 [No Abstract] [Full Text] [Related]
3. The effect of vulvovaginal atrophy on women's quality of life from an Italian cohort of the EVES study. Nappi RE; Di Carlo C; Becorpi AM; Gambacciani M; De Seta F; Ribaldone R; Benedetto C; Paoletti AM; J Obstet Gynaecol; 2020 May; 40(4):512-519. PubMed ID: 31496326 [TBL] [Abstract][Full Text] [Related]
4. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Gandhi J; Chen A; Dagur G; Suh Y; Smith N; Cali B; Khan SA Am J Obstet Gynecol; 2016 Dec; 215(6):704-711. PubMed ID: 27472999 [TBL] [Abstract][Full Text] [Related]
5. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Salvatore S; Nappi RE; Zerbinati N; Calligaro A; Ferrero S; Origoni M; Candiani M; Leone Roberti Maggiore U Climacteric; 2014 Aug; 17(4):363-9. PubMed ID: 24605832 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of a new vaginal gel for the treatment of symptoms associated with vulvovaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled study. De Seta F; Caruso S; Di Lorenzo G; Romano F; Mirandola M; Nappi RE Maturitas; 2021 May; 147():34-40. PubMed ID: 33832645 [TBL] [Abstract][Full Text] [Related]
7. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey. Kingsberg SA; Wysocki S; Magnus L; Krychman ML J Sex Med; 2013 Jul; 10(7):1790-9. PubMed ID: 23679050 [TBL] [Abstract][Full Text] [Related]
8. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom. Archer DF; Kimble TD; Lin FDY; Battucci S; Sniukiene V; Liu JH J Womens Health (Larchmt); 2018 Mar; 27(3):231-237. PubMed ID: 29193980 [TBL] [Abstract][Full Text] [Related]
9. Management of postmenopausal vulvovaginal atrophy: recommendations of the International Society for the Study of Vulvovaginal Disease. Pérez-López FR; Phillips N; Vieira-Baptista P; Cohen-Sacher B; Fialho SCAV; Stockdale CK Gynecol Endocrinol; 2021 Aug; 37(8):746-752. PubMed ID: 34169794 [TBL] [Abstract][Full Text] [Related]
10. Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning. Pinkerton JV; Bushmakin AG; Komm BS; Abraham L Maturitas; 2017 Jun; 100():57-63. PubMed ID: 28539177 [TBL] [Abstract][Full Text] [Related]
11. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey. Nappi RE; Palacios S; Panay N; Particco M; Krychman ML Climacteric; 2016 Apr; 19(2):188-97. PubMed ID: 26581580 [TBL] [Abstract][Full Text] [Related]
12. The urogenital system and the menopause. Calleja-Agius J; Brincat MP Climacteric; 2015; 18 Suppl 1():18-22. PubMed ID: 26366796 [TBL] [Abstract][Full Text] [Related]
13. The European Vulvovaginal Epidemiological Survey (EVES): prevalence, symptoms and impact of vulvovaginal atrophy of menopause. Palacios S; Nappi RE; Bruyniks N; Particco M; Panay N; Climacteric; 2018 Jun; 21(3):286-291. PubMed ID: 29553288 [TBL] [Abstract][Full Text] [Related]
14. Vulvovaginal atrophy of menopause and its impact on sexual function in an Italian clinical cohort of post-menopausal women. Nappi RE; Guida M; Marchesoni D; Cianci A; Pellegrino A; Remorgida V; Di Paolantonio T; Benedetti Panici P; J Obstet Gynaecol; 2021 Feb; 41(2):290-297. PubMed ID: 33432869 [TBL] [Abstract][Full Text] [Related]
15. The Association Between Vulvovaginal Atrophy Symptoms and Quality of Life Among Postmenopausal Women in the United States and Western Europe. DiBonaventura M; Luo X; Moffatt M; Bushmakin AG; Kumar M; Bobula J J Womens Health (Larchmt); 2015 Sep; 24(9):713-22. PubMed ID: 26199981 [TBL] [Abstract][Full Text] [Related]
16. Pelvic floor muscles training to reduce symptoms and signs of vulvovaginal atrophy: a case study. Mercier J; Morin M; Lemieux MC; Reichetzer B; Khalifé S; Dumoulin C Menopause; 2016 Jul; 23(7):816-20. PubMed ID: 27219835 [TBL] [Abstract][Full Text] [Related]
17. Vulvar and Vaginal Atrophy: Physiology, Clinical Presentation, and Treatment Considerations. Lev-Sagie A Clin Obstet Gynecol; 2015 Sep; 58(3):476-91. PubMed ID: 26125962 [TBL] [Abstract][Full Text] [Related]
18. Short-Term Efficacy and Safety of Non-Ablative Laser Treatment Alone or with Estriol or Moisturizers in Postmenopausal Women with Vulvovaginal Atrophy. Alvisi S; Lami A; Baldassarre M; Lenzi J; Mancini I; Seracchioli R; Meriggiola MC J Sex Med; 2022 May; 19(5):761-770. PubMed ID: 35370104 [TBL] [Abstract][Full Text] [Related]
19. Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Nappi RE; Palacios S Climacteric; 2014 Feb; 17(1):3-9. PubMed ID: 24423885 [TBL] [Abstract][Full Text] [Related]
20. Genitourinary syndrome of the menopause--dawn of a new era? Panay N Climacteric; 2015; 18 Suppl 1():13-7. PubMed ID: 26366795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]